市场准入

Costello Medical 专注于运用最有力的科学证据展示产品的价值,这一点在我们的市场准入工作中表现得尤为明显

市场准入
market-access

我们认为清楚明确的市场准入战略以及沟通的时机和一致性对于市场准入的成功至关重要。因此,我们在制定市场准入战略计划时,除了预测潜在挑战并提供解决方案外,还会全面考量产品的所有相关证据、市场竞争格局以及各利益相关方的观点

从价值文档到面向产品采购者的经济学工具,我们的各类市场准入材料始终以准确易懂且最合适的形式创造性地呈现给受众。为了确保前后沟通的一致性,我们在编写各类材料时始终坚持以关键价值信息为基础

我们如何支持您的项目?

市场准入计划和战略
市场准入计划和战略
证据生成
证据生成
内部资源与培训
内部资源与培训
利益相关方的参与和材料准备
利益相关方的参与和材料准备

我们的多学科市场准入项目经验包括:

市场准入计划和战略
  • 战略规划和证据生成计划
  • 产品生命周期医学沟通计划制定,如学术出版计划
  • 关键价值信息的开发和验证
证据生成
内部资源与培训
  • 全球和本地价值文档
  • 市场准入内部培训资料及研讨会
  • 异议处理文件
  • 本地市场准入全景分析
利益相关方的参与和材料提供
  • HTA 申报
  • AMCP 文档
  • 英国潜力创新药物 (Promising Innovative Medicine, PIM) 认定申请及早期获得药物计划 (Early Access to Medicines, EAMS) 档案
  • 市场准入白皮书
  • 原始研究和文献综述撰写发表
  • 交互式价值材料
  • 量身定制的循证产品手册
  • Advanced budgetary notification (ABN) 相关材料
  • 地区性市场准入材料 (formulary pack)

案例展示

全球市场准入工具

A newly-created global market access department asked us to develop materials to communicate the value of one of their products and, at the same time, to help them convince their organisation of the advantages of coordinated worldwide market access strategies for their key products.

We conducted pragmatic literature reviews and used the evidence to develop a compelling, evidence-based value proposition for the product, highlighting its value through clear, concise value statements. Feedback was collated on the value proposition through a value messaging workshop attended by key internal stakeholders and an affiliate questionnaire, which enabled the client to reach consensus on the value statements and ensured that the messages resonated across markets. The value proposition set the standard for how the technology should be communicated and was used to align value messaging for all subsequent value materials.

With the value proposition developed, we compiled a global value dossier. This adhered closely to the value proposition, explained the key evidence supporting each claim to form a central point of reference for all users, and was designed to respond to the needs and challenges of teams in key markets. We anticipated the market access department’s need to explain this unfamiliar tool to senior management and other colleagues, so developed tailored training slides to convey the value dossier methodology, content and practical purpose to internal stakeholders.

The value materials were met with a positive reception across the organisation and the market access team gained approval to drive the market access activities of two further technologies with further bespoke value dossiers. These have since fed into impactful customer-facing materials, including objection handling documents, interactive value dossiers, sales force training and health economic modelling.

Explore market access

We can offer a range of different review types, suited to the individual project. Pragmatic or systematic literature reviews are conducted in collaboration with our in-house evidence development experts to assimilate the most relevant and compelling evidence for the value of a product.

Developed closely with the client, using the results of the evidence identification and synthesis to explain the value messages of a product in an engaging and impactful style.

Bringing together key internal stakeholders to provide constructive feedback and achieve consensus on the content of the value proposition through presentations, group discussions and break-out sessions.

Developed to collate local affiliate requirements for the value proposition and dossier, and so ensure that the materials are tailored to their needs as far as possible.

Developed using feedback received from local affiliates and at the value messaging workshop, the finalised value proposition promotes alignment of the most impactful value messages for a product, and can feed into all activities supporting the technology to ensure consistent messaging.

A central repository covering information such as product design, unmet need, clinical, registry, economic and competitor data, so demonstrating the value of a product and differentiating it from competitors from the perspective of clinical and non-clinical stakeholders. This resource can be used to inform internal or customer-facing materials.

To prepare Sales Reps for typical clinical and economic questions they may have to answer from customers, and align the team on delivering effective, evidence-based responses.

A visual, interactive and easily-navigated summary of the value dossier, designed to facilitate discussions on the value of a product with clinical or non-clinical customers.

A training event consisting of presentations, role-play and Q&A sessions to ensure that the sales force understand the methodology behind the materials and how they can be used to effectively engage with customers.

To demonstrate the economic value of a product to internal and external stakeholders and support market access. In collaboration with our in-house health economics experts we can develop robust Markov models, discrete event simulations, budget impact models or cost-of-illness models to suit your exact requirements.

价值工具的调整以及全球循证医学培训

We were approached by a major medical device company which had recently established a small health economics and market access team with their Asia-Pacific structure.

Initially, our priority was to develop a compelling, regionally-relevant value proposition for an implantable device of strategic importance to the regional revenue. Once validated, multiple versions of the full value slideset were adapted to target different priority countries across the region, including South East Asia, Australia and Korea. Each slideset was tailored using locally relevant data, including disease burden, clinical and economic evidence identified via pragmatic searches using local languages, including Mandarin and Korean. The slideset was highly visual, including animations to illustrate the disease pathway to non-clinical stakeholders, and videos to educate potential clinical referrers and implanters about the simple nature of the implanting procedure. Once finalised, the slideset was developed as an interactive digital tool which could be rolled out to the sales team’s iPads.

As the sales team had limited experience in selling using health economic evidence, we developed a training video to explain the structure and content of the tool. The training video was accompanied by a survey to seek feedback from end users on the relevance of the value messages for additional markets, and to ensure that each individual developed a customer exposure plan once the tool was launched. We also conducted face-to-face training with the growing China sales and marketing teams, including an entry-level introduction to basic principles of health economics which would be needed for the team to engage with economic stakeholders.

In order to upskill the client’s teams in the region, we designed a more comprehensive training course covering principles of evidence-based medicine, including clinical trial design, scientific publications, statistics, epidemiology and health economics. The training course was developed as an e-Module which could be deployed via the company’s learning management system. The training was learner-orientated, featuring examples from across the client’s therapeutic portfolio to illustrate the learning objectives in a relevant and engaging manner.

The learning e-Modules went on to be adopted beyond the Asia-Pacific region, with global approval to train sales and marketing teams worldwide. The modules were successfully integrated at a country level for existing teams as well as incorporated as part of the onboarding process for new staff. The course allowed all teams to increase their ability to sell in an evidence-based manner using tools such as value slidesets and health economic apps that we had prepared. Overall, the project strengthened the role of the health economics and market access function within the company, contributing to increased investment in market access activities.

文章及学术论文

请查看以下研究或点击这里检索更多信息